NOURISH PLUS KIDS

Vitamin D3 and Calcium are among the most critically researched nutrients in pediatric health, with deficiency affecting an estimated 40-“60% of children globally depending on geography and skin tone. A landmark randomized controlled trial published in 2006 found that Vitamin D3 supplementation at 200-“400 IU daily in infants and toddlers significantly improved serum 25-hydroxyvitamin D levels and reduced the incidence of rickets over a 12-month follow-up period (PMID: 16549493). Calcium at 200mg per serving contributes meaningfully to the 700-“1,000mg daily requirement for children aged 2-“8, supporting the matrix mineralization that underpins skeletal growth and dental enamel formation. Research from the American Journal of Clinical Nutrition demonstrated that calcium intake during early childhood is predictive of peak bone mass achieved in adolescence, with children receiving adequate calcium showing up to 5% greater bone mineral density by age 10 (PMID: 10232622).

Vitamin A at 400mcg (approximately 1,333 IU as retinol activity equivalents) plays an irreplaceable role in mucosal immunity, visual function, and epithelial cell differentiation. A landmark Cochrane-referenced trial spanning multiple countries demonstrated that Vitamin A supplementation in children aged 6 months to 5 years reduced all-cause mortality by 24% and diarrhea-related morbidity by up to 28% compared to placebo (PMID: 21249663). Vitamin C at 125mg -— exceeding the RDA of 15-“45mg for children -— potently regenerates oxidized Vitamin E, stimulates collagen biosynthesis, and enhances non-heme iron absorption by up to 3-fold when co-administered, which directly amplifies the efficacy of the 5mg iron component in this formulation. A randomized pediatric trial confirmed that ascorbic acid co-ingested with iron-fortified foods raised hemoglobin concentrations significantly more than iron alone over a 16-week intervention (PMID: 9701186).

Iron at 5mg per serving is carefully dosed to replenish stores without approaching toxicity thresholds. Iron-deficiency anemia affects approximately 20-“25% of children under 5 globally and is independently associated with impaired cognitive development, reduced attention span, and lower academic performance. A double-blind RCT published in Pediatrics demonstrated that iron supplementation in iron-deficient children aged 6-“24 months improved developmental scores on the Bayley Scales by a statistically significant margin over 4 months, with effect sizes of 0.3-“0.5 standard deviations in mental and psychomotor indices (PMID: 11389237). The B-Complex vitamins -— including B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6, B7 (biotin), and B12 -— collectively support mitochondrial energy metabolism via the citric acid cycle and electron transport chain, and are essential cofactors in neurotransmitter synthesis including serotonin, dopamine, and GABA pathways. Folate (B9) and B12 are particularly critical for DNA methylation and neural tube-adjacent brain development during early childhood.

The safety profile of this formulation is well-established across pediatric nutrition literature. All six ingredients are dosed within or below the Tolerable Upper Intake Levels (ULs) established by the Institute of Medicine for children aged 2-“8. Vitamin A at 400mcg is well below the pediatric UL of 600-“900mcg RAE, and iron at 5mg is far below the 40mg UL for children, minimizing gastrointestinal side effects that are common at higher therapeutic doses. A systematic review of pediatric multivitamin safety published in 2012 concluded that standard-dose multivitamins containing these micronutrients produced no significant adverse events in children over follow-up periods of 12-“24 months, with the most commonly reported side effects being mild and transient GI discomfort in fewer than 3% of participants (PMID: 22101980).